OUR PRODUCTS

MOBILE APPS

GENERAL INFO

JANX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Janux Therapeutics (JANX) Earnings Date & Reports

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

JANX is expected to report earnings to fall 4.69% to -52 cents per share on November 11

Janux Therapeutics JANX Stock Earnings Reports

Q3'25

Est.

$-0.52

Q2'25

Missed

by $0.09

Q1'25

Missed

by $0.01

Q4'24

Beat

by $0.07

Q3'24

Missed

by $0.18

The last earnings report on August 07 showed earnings per share of -55 cents, missing the estimate of -46 cents. With 190.82K shares outstanding, the current market capitalization sits at 1.37B.

View a ticker or compare two or three

Compare

JANX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For JANX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. JANX showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

10955 Vista Sorrento Parkway

Phone

+1 858 751-4493

Employees

Web

https://www.januxrx.com